HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

QYUNS-B

21.620

+1.2606.19%

Volume:471.20K

Turnover:10.11M

Market Cap:4.91B

PE:-12.91

High:22.120

Open:20.880

Low:20.200

Close:20.360

52wk High:36.500

52wk Low:5.950

Shares:227.07M

HK Float Shares:227.07M

Volume Ratio:1.02

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.675

ROE:-68.26%

ROA:-10.67%

PB:19.80

PE(LYR):-12.91

PS:13.99

Loading ...

Overview Company News Filings

BRIEF-Qyuns Therapeutics Says QX027N Injection Obtains Clinical Trial Approvals From Center For Drug Evaluation, NMPA

QYUNS-B (02509): Long-acting Bispecific Antibody QX027N Receives Two Clinical Trial Approvals

Qyuns Therapeutics Wins Clinical Trial Approval for Bispecific Antibody QX027N

Qyuns Therapeutics Co - QX027n Injection Obtains 2 Clinical Trial Approvals From Center for Drug Evaluation of Nmpa

THOMSON REUTERS

HK Stock Movement | QYUNS-B (02509) Surges Over 10% as It Plans to Renew QX001S Framework Agreement Annual Caps, Showcasing Continued Value of Autoimmune Bispecific Antibody

Qyuns Therapeutics (Stock Code: 2509) Announces Renewal of Annual Caps for QX001S Framework Agreement and Proposes Amendments to Articles

Bulletin Express

Qyuns Therapeutics Plans Higher Annual Caps for Huadong Transactions Through 2028; Shares Rise 4%

MT Newswires Live

Hong Kong Stock Buyback Summary | November 12

Qyuns Therapeutics (2509) Announces Renewal of QX001S Annual Caps and Proposes Articles Amendments

Bulletin Express

QYUNS-B (02509) Repurchased 52,200 Shares for Approximately HK$998,800 on November 11

BRIEF-Qyuns Therapeutics Repurchased Total 549,800 Ordinary Shares From Nov 6 To Nov 10

Qyuns Therapeutics Co. Ltd. repurchases units totaling approximately HK$11.07 million

Qyuns Therapeutics - Repurchased Total 549,800 Ordinary Shares on the Exchange From Nov 6 to Nov 10

THOMSON REUTERS

Qyuns (02509) Publishes Next Day Disclosure Return, Highlights Share Repurchase Transactions

Bulletin Express

Hong Kong Stock Buyback Summary | November 10

QYUNS-B Spent HK$6.07 Million to Repurchase 304,200 Shares on November 7

Qyuns Therapeutics (02509) Announces Share Repurchase Update

Bulletin Express

QYUNS-B (02509) Repurchases 89,200 Shares for HK$1.996 Million on November 6

Qyuns Therapeutics Files HKEX Disclosure on Repurchase of 89,200 Shares for HKD 1.99 Million

HK Stock Movement | QYUNS-B (02509) Surges Over 11% Intraday as QX031N Licensed to Roche; Analysts Highlight Deal's Scarcity Value

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02509/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02509","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"QYUNS-B","latestPrice":21.62,"timestamp":1763096711143,"preClose":20.36,"halted":0,"volume":471200,"delay":0,"floatShares":227071600,"shares":227071600,"eps":-1.6750144741012951,"marketStatus":"Trading","change":1.26,"latestTime":"11-14 13:09:26","open":20.88,"high":22.12,"low":20.2,"amount":10111596,"amplitude":0.094303,"askPrice":21.68,"askSize":400,"bidPrice":21.56,"bidSize":3200,"shortable":3,"etf":0,"ttmEps":-0.9459080518051791,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1763107800000},"marketStatusCode":2,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":20.36,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":1.01742,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","floatShares":227071600,"roa":"-10.67%","roe":"-68.26%","lyrEps":-1.675014,"volumeRatio":1.01742,"shares":227071600,"dividePrice":0,"high":22.12,"amplitude":0.094303,"preClose":20.36,"low":20.2,"week52Low":5.95,"pbRate":"19.80","psRate":"13.99","week52High":36.5,"institutionHeld":0,"latestPrice":21.62,"committee":0.777778,"eps":-1.6750144741012951,"divideRate":0,"volume":471200,"delay":0,"ttmEps":-0.9459080518051791,"open":20.88,"prevYearClose":7.38,"prevWeekClose":19.25,"prevMonthClose":21.78,"prevQuarterClose":34.88,"fiveDayClose":19.25,"twentyDayClose":28.5,"sixtyDayClose":24.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02509\",params:#limit:5,,,undefined,":[{"date":"2025-03-28","symbol":"02509","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"Post Market","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-15","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723685400000,"name":null,"time":"","dateTimestamp":1723651200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02509\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02509\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02509\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02509","date":"2025-11-12","current":-21.523883,"percent":0.145679,"low":-38.274716,"twenty":-12.381731,"median":-9.104252,"eighty":-5.147637,"high":-3.10587,"avg":-11.11198,"sd":8.251599,"marketCap":4302922400},"quantilePoints":[{"date":"2024-03-22","current":-9.005941,"twenty":-9.920087,"median":-9.005941,"eighty":-8.797979,"marketCap":4652400020},{"date":"2024-03-28","current":-9.367246,"twenty":-9.484937,"median":-9.005941,"eighty":-8.416995,"marketCap":4821843660},{"date":"2024-04-05","current":-8.872714,"twenty":-9.396669,"median":-8.977885,"eighty":-8.598751,"marketCap":4565907160},{"date":"2024-04-12","current":-9.165919,"twenty":-9.386227,"median":-9.126184,"eighty":-8.830039,"marketCap":4719469060},{"date":"2024-04-19","current":-9.074252,"twenty":-9.304842,"median":-9.125412,"eighty":-8.934406,"marketCap":4668281760},{"date":"2024-04-26","current":-9.882424,"twenty":-9.513374,"median":-9.232059,"eighty":-8.994719,"marketCap":5077780160},{"date":"2024-05-03","current":-10.208268,"twenty":-9.517937,"median":-9.234052,"eighty":-9.046928,"marketCap":5241579520},{"date":"2024-05-10","current":-10.950727,"twenty":-10.058378,"median":-9.328243,"eighty":-9.081967,"marketCap":6018140360},{"date":"2024-05-17","current":-11.513141,"twenty":-10.522167,"median":-9.424295,"eighty":-9.09098,"marketCap":6317937020},{"date":"2024-05-24","current":-11.397533,"twenty":-11.287555,"median":-9.513128,"eighty":-9.098359,"marketCap":6240211960},{"date":"2024-05-31","current":-10.960491,"twenty":-11.380385,"median":-9.702863,"eighty":-9.110289,"marketCap":6007036780},{"date":"2024-06-07","current":-9.736726,"twenty":-11.329803,"median":-9.882424,"eighty":-9.125257,"marketCap":5329718400},{"date":"2024-06-14","current":-9.786262,"twenty":-11.239813,"median":-9.736726,"eighty":-9.134131,"marketCap":5351925560},{"date":"2024-06-21","current":-11.51586,"twenty":-11.394726,"median":-9.834343,"eighty":-9.179147,"marketCap":6284626280},{"date":"2024-06-28","current":-7.449742,"twenty":-11.394726,"median":-9.882424,"eighty":-9.134131,"marketCap":4063910280},{"date":"2024-07-05","current":-8.013266,"twenty":-11.3835,"median":-9.736726,"eighty":-9.096784,"marketCap":4370369088},{"date":"2024-07-12","current":-8.782148,"twenty":-11.375713,"median":-9.612459,"eighty":-8.973485,"marketCap":4796746560},{"date":"2024-07-19","current":-8.033889,"twenty":-11.260937,"median":-9.536435,"eighty":-8.759388,"marketCap":4388134816},{"date":"2024-07-26","current":-8.627957,"twenty":-11.24224,"median":-9.513744,"eighty":-8.627957,"marketCap":4730125080},{"date":"2024-08-02","current":-9.119354,"twenty":-11.155317,"median":-9.51436,"eighty":-8.659337,"marketCap":4996611000},{"date":"2024-08-09","current":-9.602516,"twenty":-11.096166,"median":-9.502501,"eighty":-8.759388,"marketCap":5296407660},{"date":"2024-08-16","current":-9.659156,"twenty":-11.082764,"median":-9.523303,"eighty":-8.782148,"marketCap":5329718400},{"date":"2024-08-23","current":-11.457751,"twenty":-11.24224,"median":-9.560506,"eighty":-8.785621,"marketCap":5274200500},{"date":"2024-08-30","current":-11.261539,"twenty":-11.260937,"median":-9.602516,"eighty":-8.853804,"marketCap":5218682600},{"date":"2024-09-06","current":-12.381731,"twenty":-11.301814,"median":-9.616314,"eighty":-8.872714,"marketCap":5740550860},{"date":"2024-09-13","current":-12.966504,"twenty":-11.41285,"median":-9.666597,"eighty":-8.919616,"marketCap":5995933200},{"date":"2024-09-20","current":-13.175636,"twenty":-11.495182,"median":-9.727036,"eighty":-8.943786,"marketCap":6129176160},{"date":"2024-09-27","current":-11.412309,"twenty":-11.503472,"median":-9.834343,"eighty":-8.968754,"marketCap":5340821980},{"date":"2024-10-04","current":-10.630177,"twenty":-11.500266,"median":-9.955419,"eighty":-8.992959,"marketCap":4952196680},{"date":"2024-10-10","current":-9.640046,"twenty":-11.496891,"median":-9.984689,"eighty":-9.012278,"marketCap":4463639160},{"date":"2024-10-18","current":-7.823087,"twenty":-11.483911,"median":-9.882424,"eighty":-8.891475,"marketCap":3602001352},{"date":"2024-10-25","current":-6.637022,"twenty":-11.464072,"median":-9.731881,"eighty":-8.768492,"marketCap":3055705216},{"date":"2024-11-01","current":-6.266219,"twenty":-11.439791,"median":-9.666597,"eighty":-8.552796,"marketCap":2886930800},{"date":"2024-11-08","current":-6.11978,"twenty":-11.412634,"median":-9.628889,"eighty":-8.354641,"marketCap":2798102160},{"date":"2024-11-15","current":-4.903744,"twenty":-11.406399,"median":-9.610023,"eighty":-8.146037,"marketCap":2225157432},{"date":"2024-11-22","current":-4.446271,"twenty":-11.39192,"median":-9.574881,"eighty":-7.917147,"marketCap":2016410128},{"date":"2024-11-29","current":-5.262129,"twenty":-11.380385,"median":-9.536435,"eighty":-7.700796,"marketCap":2385048984},{"date":"2024-12-06","current":-5.795133,"twenty":-11.346153,"median":-9.513744,"eighty":-7.24659,"marketCap":2620444880},{"date":"2024-12-13","current":-4.23234,"twenty":-11.292835,"median":-9.462151,"eighty":-6.614509,"marketCap":1912036476},{"date":"2024-12-20","current":-3.65763,"twenty":-11.272236,"median":-9.353096,"eighty":-6.423955,"marketCap":1643329840},{"date":"2024-12-27","current":-3.704989,"twenty":-11.261539,"median":-9.289241,"eighty":-6.377951,"marketCap":1663316284},{"date":"2025-01-03","current":-3.459219,"twenty":-11.261057,"median":-9.234052,"eighty":-6.353973,"marketCap":1554501200},{"date":"2025-01-10","current":-3.422771,"twenty":-11.250301,"median":-9.146052,"eighty":-6.232964,"marketCap":1532294040},{"date":"2025-01-17","current":-3.325837,"twenty":-11.24332,"median":-9.119354,"eighty":-5.607796,"marketCap":1490100436},{"date":"2025-01-24","current":-3.940539,"twenty":-11.188065,"median":-9.092192,"eighty":-5.378133,"marketCap":1776572800},{"date":"2025-01-28","current":-4.706176,"twenty":-11.17068,"median":-9.087355,"eighty":-5.266211,"marketCap":2131887360},{"date":"2025-02-07","current":-3.301677,"twenty":-11.154739,"median":-9.066381,"eighty":-4.958001,"marketCap":1487879720},{"date":"2025-02-14","current":-3.418254,"twenty":-11.143754,"median":-8.989713,"eighty":-4.539173,"marketCap":1536735472},{"date":"2025-02-21","current":-3.43891,"twenty":-11.106485,"median":-8.919616,"eighty":-4.354459,"marketCap":1554501200},{"date":"2025-02-28","current":-3.351703,"twenty":-11.093486,"median":-8.819713,"eighty":-4.122814,"marketCap":1510086880},{"date":"2025-03-07","current":-3.387392,"twenty":-11.071174,"median":-8.759388,"eighty":-3.975573,"marketCap":1532294040},{"date":"2025-03-14","current":-5.398225,"twenty":-11.023325,"median":-8.622598,"eighty":-3.975573,"marketCap":2442787600},{"date":"2025-03-21","current":-4.408646,"twenty":-11.005989,"median":-8.475358,"eighty":-3.996365,"marketCap":1994202968},{"date":"2025-03-28","current":-4.427424,"twenty":-10.958538,"median":-8.354936,"eighty":-4.069456,"marketCap":1998644400},{"date":"2025-04-03","current":-5.532239,"twenty":-10.950727,"median":-8.251895,"eighty":-4.071454,"marketCap":1987540820},{"date":"2025-04-11","current":-5.176788,"twenty":-10.949179,"median":-8.134698,"eighty":-4.113712,"marketCap":1843194280},{"date":"2025-04-17","current":-5.605956,"twenty":-10.931954,"median":-8.013266,"eighty":-4.15012,"marketCap":1998644400},{"date":"2025-04-25","current":-6.813611,"twenty":-10.860673,"median":-7.855635,"eighty":-4.203093,"marketCap":2433904736},{"date":"2025-05-02","current":-6.97286,"twenty":-10.741685,"median":-7.823087,"eighty":-4.240312,"marketCap":2496084784},{"date":"2025-05-09","current":-6.850326,"twenty":-10.62989,"median":-7.688151,"eighty":-4.256936,"marketCap":2469436192},{"date":"2025-05-16","current":-6.660384,"twenty":-10.625613,"median":-7.362552,"eighty":-4.28571,"marketCap":2420580440},{"date":"2025-05-23","current":-6.920763,"twenty":-10.596701,"median":-7.188701,"eighty":-4.327055,"marketCap":2522733376},{"date":"2025-05-30","current":-6.975387,"twenty":-10.531077,"median":-7.035719,"eighty":-4.335168,"marketCap":2553823400},{"date":"2025-06-06","current":-8.954176,"twenty":-10.530643,"median":-7.056435,"eighty":-4.354459,"marketCap":3286659680},{"date":"2025-06-13","current":-10.1118,"twenty":-10.525842,"median":-7.245424,"eighty":-4.362058,"marketCap":3713037152},{"date":"2025-06-20","current":-9.295434,"twenty":-10.49786,"median":-7.449742,"eighty":-4.377592,"marketCap":3406578344},{"date":"2025-06-27","current":-9.088195,"twenty":-10.44408,"median":-7.654473,"eighty":-4.399074,"marketCap":3339956864},{"date":"2025-07-04","current":-9.256954,"twenty":-10.441448,"median":-7.771425,"eighty":-4.408646,"marketCap":3402136912},{"date":"2025-07-11","current":-9.278386,"twenty":-10.438605,"median":-7.855635,"eighty":-4.408983,"marketCap":3406578344},{"date":"2025-07-18","current":-10.375245,"twenty":-10.375245,"median":-8.023578,"eighty":-4.415927,"marketCap":3806307224},{"date":"2025-07-25","current":-11.242346,"twenty":-10.444738,"median":-8.163045,"eighty":-4.427424,"marketCap":4139414624},{"date":"2025-08-01","current":-12.956889,"twenty":-10.531115,"median":-8.317696,"eighty":-4.446271,"marketCap":4741228660},{"date":"2025-08-08","current":-12.531071,"twenty":-10.816023,"median":-8.356409,"eighty":-4.497422,"marketCap":4596882120},{"date":"2025-08-15","current":-13.616918,"twenty":-10.950727,"median":-8.486422,"eighty":-4.706176,"marketCap":4987728136},{"date":"2025-08-22","current":-28.922954,"twenty":-11.024815,"median":-8.611071,"eighty":-4.860396,"marketCap":6035906088},{"date":"2025-08-29","current":-26.076607,"twenty":-11.152426,"median":-8.643647,"eighty":-4.89511,"marketCap":5467884128},{"date":"2025-09-05","current":-27.424941,"twenty":-11.24224,"median":-8.759388,"eighty":-4.895913,"marketCap":5744911480},{"date":"2025-09-12","current":-33.976118,"twenty":-11.261539,"median":-8.783884,"eighty":-4.903744,"marketCap":7130048240},{"date":"2025-09-19","current":-32.137812,"twenty":-11.3835,"median":-8.872714,"eighty":-4.920955,"marketCap":6739485088},{"date":"2025-09-26","current":-31.917438,"twenty":-11.446602,"median":-8.942813,"eighty":-4.93749,"marketCap":6675905040},{"date":"2025-10-03","current":-36.693474,"twenty":-11.494681,"median":-8.957754,"eighty":-4.939756,"marketCap":7693185808},{"date":"2025-10-10","current":-31.866218,"twenty":-11.50418,"median":-8.989713,"eighty":-4.971797,"marketCap":6671363608},{"date":"2025-10-17","current":-31.02267,"twenty":-11.536491,"median":-9.052042,"eighty":-5.060821,"marketCap":6489706328},{"date":"2025-10-24","current":-25.824743,"twenty":-11.67702,"median":-9.080681,"eighty":-5.119056,"marketCap":5404304080},{"date":"2025-10-31","current":-23.597698,"twenty":-11.854109,"median":-9.087898,"eighty":-5.129572,"marketCap":4945619448},{"date":"2025-11-07","current":-20.869587,"twenty":-12.197299,"median":-9.096784,"eighty":-5.138538,"marketCap":4371128300},{"date":"2025-11-12","current":-20.543563,"twenty":-12.381731,"median":-9.104252,"eighty":-5.147637,"marketCap":4302922400}],"updateTime":1763058629729},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02509\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583591727","title":"BRIEF-Qyuns Therapeutics Says QX027N Injection Obtains Clinical Trial Approvals From Center For Drug Evaluation, NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2583591727","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583591727?lang=en_us&edition=fundamental","pubTime":"2025-11-13 23:16","pubTimestamp":1763046968,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics Says QX027N Injection Obtains Clinical Trial Approvals From Center For Drug Evaluation, NMPANov 13  - Qyuns Therapeutics Co Ltd 2509.HK:QX027N INJECTION OBTAINS 2 CLINICAL TRIAL APPROVALS FROM CENTER FOR DRUG EVALUATION OF NMPAFurther company coverage: 2509.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP11W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1166996934","title":"QYUNS-B (02509): Long-acting Bispecific Antibody QX027N Receives Two Clinical Trial Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=1166996934","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166996934?lang=en_us&edition=fundamental","pubTime":"2025-11-13 22:20","pubTimestamp":1763043613,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that its self-developed long-acting bispecific antibody, QX027N injection, has obtained implicit clinical trial approvals (Acceptance Nos.: CXSL2500757, CXSL2500758) from...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2583596331","title":"Qyuns Therapeutics Wins Clinical Trial Approval for Bispecific Antibody QX027N","url":"https://stock-news.laohu8.com/highlight/detail?id=2583596331","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583596331?lang=en_us&edition=fundamental","pubTime":"2025-11-13 22:14","pubTimestamp":1763043267,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co. Ltd. has announced that its independently developed long-acting bispecific antibody, QX027N injection, has obtained two clinical trial approvals from the Center for Drug Evaluation of the National Medical Products Administration in China. The approvals cover the treatment of asthma and atopic dermatitis, marking a significant milestone for Qyuns Therapeutics' innovative pipeline targeting autoimmune and allergic diseases. QX027N is now officially entering the clinical trial stage. The company emphasized its commitment to advancing research and providing more effective and convenient treatment options for patients with asthma and atopic dermatitis. No other organizations were reported to have received funding or approvals as part of this announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDLj0fvH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2583596813","title":"Qyuns Therapeutics Co - QX027n Injection Obtains 2 Clinical Trial Approvals From Center for Drug Evaluation of Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2583596813","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583596813?lang=en_us&edition=fundamental","pubTime":"2025-11-13 22:12","pubTimestamp":1763043159,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP11W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1141670285","title":"HK Stock Movement | QYUNS-B (02509) Surges Over 10% as It Plans to Renew QX001S Framework Agreement Annual Caps, Showcasing Continued Value of Autoimmune Bispecific Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=1141670285","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141670285?lang=en_us&edition=fundamental","pubTime":"2025-11-13 11:12","pubTimestamp":1763003536,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) rose more than 10%, reaching HK$20.92 by the time of writing, with a trading volume of HK$10.6024 million. The company recently announced that its board has considered the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1115318441","title":"Qyuns Therapeutics (Stock Code: 2509) Announces Renewal of Annual Caps for QX001S Framework Agreement and Proposes Amendments to Articles","url":"https://stock-news.laohu8.com/highlight/detail?id=1115318441","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115318441?lang=en_us&edition=fundamental","pubTime":"2025-11-12 12:22","pubTimestamp":1762921331,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics (Stock Code: 2509) has released an announcement regarding continuing connected transactions linked to its QX001S Framework Agreement with Zhongmei Huadong. Previously, annual caps...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"gpt_icon":0},{"id":"2582348601","title":"Qyuns Therapeutics Plans Higher Annual Caps for Huadong Transactions Through 2028; Shares Rise 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582348601","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582348601?lang=en_us&edition=fundamental","pubTime":"2025-11-12 11:25","pubTimestamp":1762917932,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics  plans to renew and raise annual caps for its continuing transactions with shareholder Zhongmei Huadong for 2026 to 2028, supported by growing sales of its psoriasis treatment Sailexin , according to a Tuesday Hong Kong bourse filing.Shares of the biotech firm rose nearly 4% in Wednesday morning trade.Under the proposed limits, payments from Zhongmei Huadong for product supply could reach 55 million yuan in 2028, while profit-sharing payments may rise to as much as 290 million yuan.The transactions are conducted under the QX001S framework agreement, which covers joint development and exclusive commercialization of Sailexin in mainland China, the filing said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK4139","BK4007","02509","BK4539","LENZ"],"gpt_icon":0},{"id":"1126935085","title":"Hong Kong Stock Buyback Summary | November 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1126935085","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126935085?lang=en_us&edition=fundamental","pubTime":"2025-11-12 09:12","pubTimestamp":1762909952,"startTime":"0","endTime":"0","summary":"On November 11, 2025, multiple companies conducted share buybacks, including MOBI DEV (00947), FOUNDER HOLD (00418), NETDRAGON (00777), EDIANYUN (02416), GREENTOWN SER (02869), TENFU (06868), LEON...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00799","BK1574","00383","BK1222","BK1583","BK1507","LU1282651048.USD","LU0293314216.USD","BK1599","00947","LU0821914370.USD","01588","BK1109","BK1506","BK1155","BK1589","02142","BK1593","BK1505","00777","BK1526","LU1188198961.HKD","BK1191","BK1226","BK1500","LU0244354667.USD","02038","BK1562","SG9999001440.SGD","00732","LU1051769294.HKD","BK1542","LU0359202008.SGD","02171","06186","BK1587","BK1521","02869","BK1253","LU0173614495.USD","02509","LU1023057109.AUD","LU1048596156.SGD","LU0823426308.USD","BK1535","BK1209","BK1161","LU0181495838.USD","02039","LU2097828631.EUR","LU0348805143.USD","BK1189","BK1517","00386","02299","02251","00909","02282","LU0359201885.HKD","BK1591","08188","LU1051768304.USD","03798","LU0651946864.USD","02469","BK1104","BK1508","BK1575","LU2097828474.EUR","01919","BK1528","LU2097828557.USD","BK1531","01586","LU1515016050.SGD","06826","02598","02416","BK1170","LU0463099449.HKD","BK1597","00418","BK1607","09959","00103","LU0140636845.USD","LU1831875114.USD","BK1137","BK1117","BK1172","BK1229","BK1619","BK1553","BK1237","BK1167","BK1183","LU0828237940.HKD","01681","LU0287142896.SGD","BK1202","BK1160","BK1148","BK1149","02486","BK1518","01066","BK1258","BK1519","BK1585","LU0359201612.USD","LU2097828714.EUR","BK1504","LU0326950275.SGD","BK1225","LU2097828805.USD","BK1103","LU0823426480.USD","BK1606","BK1516","06868","LU0651947912.USD","BK1228","01167","BK1618"],"gpt_icon":0},{"id":"1193005181","title":"Qyuns Therapeutics (2509) Announces Renewal of QX001S Annual Caps and Proposes Articles Amendments","url":"https://stock-news.laohu8.com/highlight/detail?id=1193005181","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193005181?lang=en_us&edition=fundamental","pubTime":"2025-11-11 22:22","pubTimestamp":1762870941,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. (Stock Code: 2509) issued an announcement regarding the renewal of annual caps for its continuing connected transactions under the QX001S Framework Agreement, covering...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"gpt_icon":0},{"id":"1190677091","title":"QYUNS-B (02509) Repurchased 52,200 Shares for Approximately HK$998,800 on November 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1190677091","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190677091?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:36","pubTimestamp":1762868170,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on November 11, 2025, the company repurchased 52,200 shares at a total cost of approximately HK$998,800.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2582087084","title":"BRIEF-Qyuns Therapeutics Repurchased Total 549,800 Ordinary Shares From Nov 6 To Nov 10","url":"https://stock-news.laohu8.com/highlight/detail?id=2582087084","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582087084?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:46","pubTimestamp":1762785987,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics Repurchased Total 549,800 Ordinary Shares From Nov 6 To Nov 10Nov 10 (Reuters) - Qyuns Therapeutics Co Ltd 2509.HK:REPURCHASED TOTAL 549,800 ORDINARY SHARES ON THE EXCHANGE FROM NOV 6 TO NOV 10Further company coverage: 2509.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nFWN3WM0X5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2582872859","title":"Qyuns Therapeutics Co. Ltd. repurchases units totaling approximately HK$11.07 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582872859","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582872859?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:00","pubTimestamp":1762783228,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co. Ltd. has announced that it repurchased a total of 549,800 ordinary shares on The Stock Exchange of Hong Kong Limited, with the aggregate amount involved in the repurchases reaching approximately HK$11.07 million . The company stated that the repurchased shares will be held as treasury shares and that the share repurchase was conducted under the repurchase mandate approved by shareholders at the annual general meeting on June 20, 2025. The company emphasized that the implementation of further on-market share repurchases will be subject to market conditions and the discretion of the board.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qyuns Therapeutics Co. Ltd. published the original content used to generate this","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL3Mnh5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2582874271","title":"Qyuns Therapeutics - Repurchased Total 549,800 Ordinary Shares on the Exchange From Nov 6 to Nov 10","url":"https://stock-news.laohu8.com/highlight/detail?id=2582874271","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582874271?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:58","pubTimestamp":1762783083,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nFWN3WM0X5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1100978051","title":"Qyuns (02509) Publishes Next Day Disclosure Return, Highlights Share Repurchase Transactions","url":"https://stock-news.laohu8.com/highlight/detail?id=1100978051","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100978051?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:22","pubTimestamp":1762780932,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. (stock code 02509) released a Next Day Disclosure Return dated 10 November 2025, detailing updates in issued shares and treasury shares. The announcement outlined that on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"gpt_icon":0},{"id":"1179907428","title":"Hong Kong Stock Buyback Summary | November 10","url":"https://stock-news.laohu8.com/highlight/detail?id=1179907428","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179907428?lang=en_us&edition=fundamental","pubTime":"2025-11-10 09:12","pubTimestamp":1762737154,"startTime":"0","endTime":"0","summary":"Several Hong Kong-listed companies conducted share buybacks on November 7, 2025. Among them, China Feihe (06186) recorded the highest buyback amount, repurchasing 6 million shares for HKD 26.08...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B067MR52.USD","LU0359201612.USD","LU0163747925.USD","01358","LU1235295612.USD","IE0034224299.USD","LU0128522157.USD","IE0009570106.USD","BK1517","LU0293314216.USD","LU0737861699.HKD","LU2045819591.USD","BK1209","06826","BK1135","BK1528","LU0211977185.USD","BK1519","BK1161","LU2097828474.EUR","LU0390135688.USD","BK1583","BK1151","BK1253","BK1591","IE00B031J352.USD","02171","BK1574","00732","BK1226","02299","BK1149","SG9999001093.SGD","BK1542","00799","02416","BK1117","IE00B031HY20.USD","IE00B97KM107.HKD","00386","BK1183","BK1197","LU1051769294.HKD","BK1585","02886","02282","02509","BK1103","BK1553","BK1541","02869","LU0348825331.USD","09987","LU1102505762.USD","LU0244354667.USD","LU0072462343.USD","LU1188198961.HKD","BK1599","BK1606","09885","BK1158","SG9999014674.SGD","LU0173614495.USD","00366","BK1607","SG9999001440.SGD","BK1521","IE00B0169L03.USD","LU0417516902.SGD","LU0588546209.SGD","BK1597","LU1102505929.USD","09959","01919","08188","BK1500","LU0828237940.HKD","IE00B29SXG58.USD","LU0049112450.USD","LU0463099449.HKD","LU0348805143.USD","HK0000320223.HKD","LU0259732245.USD","01681","LU1769817179.HKD","01586","00418","LU0251143458.SGD","BK1258","00103","LU0328353924.USD","02142","LU0140636845.USD","02018","BK1104","HK0000320264.USD","LU1023057109.AUD","LU0359202008.SGD","LU1048596156.SGD","BK1535","BK1502","09966","BK1228","LU0594300419.USD","BK1170","IE0008369823.USD","LU0672654166.SGD","BK1233","01167","LU2097828714.EUR","LU2125910500.SGD","02598","LU0315179316.USD","BK1225","HK0000306701.USD","IE0031814852.USD","LU0228659784.USD","LU2097828805.USD","SG9999006597.SGD","02120","BK1588","LU1769817096.USD","LU0390135506.SGD","BK1229","LU1224709979.USD","BK1589","BK1506","SG9999003461.SGD","BK1202","LU0823426308.USD","LU0300738605.USD","BK1526","00947","BK1608","LU0471298777.SGD","01066","BK1593","LU1046422090.SGD","BK1237","LU0543330483.HKD","LU0823426480.USD","LU0651946864.USD","LU0348788117.USD","BK1155","BK1160","BK1222","BK1619","06868","02039","BK1109","LU2097828557.USD","BK1575","01588","00909","BK1137","BK1504","LU0307460666.USD","BK1100","LU0300738514.USD","LU0181495838.USD","LU0320764755.SGD","LU0651947912.USD","BK1587","LU0228367735.SGD","BK1531","LU1051768304.USD","08128","LU0048580855.USD","LU0287142896.SGD","LU1282651048.USD","BK1507","SG9999011746.SGD","LU0029875118.USD","IE0008368742.USD","02469","BK1618","IE0032834883.USD","LU0326950275.SGD","HK0000306685.HKD","LU0370786039.SGD","02486","BK1167","LU0385154629.USD","LU2279701549.SGD","BK1505","BK1562","LU0106959298.USD","02343","BK1518","BK1172","SG9999002950.SGD","LU1439103000.SGD","02319","06186","02190","LU1831875114.USD","02057","LU0821914370.USD","BK1221","LU0359201885.HKD","LU0390135332.USD","BK1516","LU0650527681.SGD","LU1048588211.SGD","LU2097828631.EUR","SG9999002828.SGD","BK1191","LU1515016050.SGD","BK1148","00777"],"gpt_icon":0},{"id":"1153986880","title":"QYUNS-B Spent HK$6.07 Million to Repurchase 304,200 Shares on November 7","url":"https://stock-news.laohu8.com/highlight/detail?id=1153986880","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153986880?lang=en_us&edition=fundamental","pubTime":"2025-11-09 11:20","pubTimestamp":1762658419,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on November 7, 2025, the company repurchased 304,200 shares at a total cost of HK$6.07 million.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1195681657","title":"Qyuns Therapeutics (02509) Announces Share Repurchase Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1195681657","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195681657?lang=en_us&edition=fundamental","pubTime":"2025-11-06 22:22","pubTimestamp":1762438951,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. announced a repurchase of 89,200 ordinary H shares on 06 November 2025. According to the company’s disclosure, the highest price for the on-exchange repurchase was HKD...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"gpt_icon":0},{"id":"1178044345","title":"QYUNS-B (02509) Repurchases 89,200 Shares for HK$1.996 Million on November 6","url":"https://stock-news.laohu8.com/highlight/detail?id=1178044345","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178044345?lang=en_us&edition=fundamental","pubTime":"2025-11-06 22:10","pubTimestamp":1762438209,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that it repurchased 89,200 shares on November 6, 2025, for a total consideration of HK$1.996 million.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2581099701","title":"Qyuns Therapeutics Files HKEX Disclosure on Repurchase of 89,200 Shares for HKD 1.99 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581099701","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581099701?lang=en_us&edition=fundamental","pubTime":"2025-11-06 22:08","pubTimestamp":1762438129,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co. Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, announcing the repurchase of 89,200 shares at a price of HKD 22.3773 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qyuns Therapeutics Co. Ltd. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL2L0Gv1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1160154147","title":"HK Stock Movement | QYUNS-B (02509) Surges Over 11% Intraday as QX031N Licensed to Roche; Analysts Highlight Deal's Scarcity Value","url":"https://stock-news.laohu8.com/highlight/detail?id=1160154147","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160154147?lang=en_us&edition=fundamental","pubTime":"2025-11-03 14:28","pubTimestamp":1762151293,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) rose more than 11% intraday before paring gains to 4.78% at HK$22.82, with a turnover of HK$12.29 million. The surge follows the company's announcement on October 28 of a global...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}]}}